297 related articles for article (PubMed ID: 12606616)
1. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
[TBL] [Abstract][Full Text] [Related]
3. Silicon analogues of the nonpeptidic GnRH antagonist AG-045572: syntheses, crystal structure analyses, and pharmacological characterization.
Barnes MJ; Burschka C; Büttner MW; Conroy R; Daiss JO; Gray IC; Hendrick AG; Tam LH; Kuehn D; Miller DJ; Mills JS; Mitchell P; Montana JG; Muniandy PA; Rapley H; Showell GA; Tebbe D; Tacke R; Warneck JB; Zhu B
ChemMedChem; 2011 Nov; 6(11):2070-80. PubMed ID: 21953839
[TBL] [Abstract][Full Text] [Related]
4. Testosterone effects on luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the mouse.
Huang BM; Leu SF; Yang HY; Norman RL
J Androl; 2001; 22(3):507-13. PubMed ID: 11330652
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.
Struthers RS; Xie Q; Sullivan SK; Reinhart GJ; Kohout TA; Zhu YF; Chen C; Liu XJ; Ling N; Yang W; Maki RA; Bonneville AK; Chen TK; Bozigian HP
Endocrinology; 2007 Feb; 148(2):857-67. PubMed ID: 17095587
[TBL] [Abstract][Full Text] [Related]
7. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
8. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
[TBL] [Abstract][Full Text] [Related]
9. Pituitary gonadotropin-releasing hormone receptors. Effects of castration, steroid replacement, and the role of gonadotropin-releasing hormone in modulating receptors in the rat.
Frager MS; Pieper DR; Tonetta SA; Duncan JA; Marshall JC
J Clin Invest; 1981 Mar; 67(3):615-23. PubMed ID: 6259205
[TBL] [Abstract][Full Text] [Related]
10. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
[TBL] [Abstract][Full Text] [Related]
12. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R).
Pelletier JC; Chengalvala MV; Cottom JE; Feingold IB; Green DM; Hauze DB; Huselton CA; Jetter JW; Kopf GS; Lundquist JT; Magolda RL; Mann CW; Mehlmann JF; Rogers JF; Shanno LK; Adams WR; Tio CO; Wrobel JE
J Med Chem; 2009 Apr; 52(7):2148-52. PubMed ID: 19271735
[TBL] [Abstract][Full Text] [Related]
14. An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.
Krsmanovic LZ; Mores N; Navarro CE; Arora KK; Catt KJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2969-74. PubMed ID: 12591945
[TBL] [Abstract][Full Text] [Related]
15. Identification of new gonadotrophin-releasing hormone partial agonists.
Leaños-Miranda A; Ulloa-Aguirre A; Cervini LA; Janovick JA; Rivier J; Conn PM
J Endocrinol; 2006 Jun; 189(3):509-17. PubMed ID: 16731782
[TBL] [Abstract][Full Text] [Related]
16. 3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization.
Tucci FC; Zhu YF; Struthers RS; Guo Z; Gross TD; Rowbottom MW; Acevedo O; Gao Y; Saunders J; Xie Q; Reinhart GJ; Liu XJ; Ling N; Bonneville AK; Chen T; Bozigian H; Chen C
J Med Chem; 2005 Feb; 48(4):1169-78. PubMed ID: 15715483
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
Harrison GS; Wierman ME; Nett TM; Glode LM
Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
[TBL] [Abstract][Full Text] [Related]
19. Novel gonadotropin-releasing hormone antagonists with substitutions at position 5.
Samant MP; Hong DJ; Croston G; Rivier C; Rivier J
Biopolymers; 2005; 80(2-3):386-91. PubMed ID: 15614806
[TBL] [Abstract][Full Text] [Related]
20. Effects of a gonadotropin-releasing hormone antagonist on gonadotropin levels in Masu salmon and Sockeye salmon.
Amano M; Ikuta K; Kitamura S
J Exp Zool A Ecol Genet Physiol; 2007 Sep; 307(9):535-41. PubMed ID: 17654691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
